Cytarabine and daunorubicin liposomal and Tafenoquine Succinate (Arakoda)
Determining the interaction of Cytarabine and daunorubicin liposomal and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cytarabine liposomal / daunorubicin liposomal
Brand name: Vyxeos
Synonyms: Cytarabine and daunorubicin (liposomal), Daunorubicin and Cytarabine (Liposomal)
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Cytarabine and daunorubicin liposomal-Tafenoquine Succinate (Krintafel)
- Cytarabine and daunorubicin liposomal-Tafinlar
- Cytarabine and daunorubicin liposomal-Tafluprost
- Cytarabine and daunorubicin liposomal-Tafluprost ophthalmic
- Cytarabine and daunorubicin liposomal-Tagamet
- Cytarabine and daunorubicin liposomal-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Cytarabine liposome Intrathecal
- Tafenoquine Succinate (Arakoda)-CytoGam
- Tafenoquine Succinate (Arakoda)-Cytogam injection
- Tafenoquine Succinate (Arakoda)-Cytomegalovirus immune globulin (CMV IG) injection
- Tafenoquine Succinate (Arakoda)-Cytomegalovirus Immune Globulin (Intravenous-Human)
- Tafenoquine Succinate (Arakoda)-Cytomegalovirus Immune Globulin IV